Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D James

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisLarysa H M Rydzewska, Sarah Burdett, Claire L Vale, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort StudySylvia H J Jochems, Frits H M van Osch, Raoul C Reulen, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
Trials|September 18, 2012
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trialMatthew R Sydes, Mahesh K B Parmar, Malcolm D Mason, et al.
BJU International|September 7, 2021
Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot studyNaheema S Gordon, Laura A Baxter, Anshita Goel, et al.
Genome Medicine|June 2, 2022
Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomesAnshita Goel, Douglas G Ward, Boris Noyvert, et al.
Plos One|February 23, 2016
Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder CancerDouglas G Ward, Laura Baxter, Naheema S Gordon, et al.
Nature|August 31, 2018
Required growth facilitators propel axon regeneration across complete spinal cord injuryMark A Anderson, Timothy M O'Shea, Joshua E Burda, et al.
European Journal of Human Genetics : EJHG|January 14, 2016
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNAFiona S Togneri, Douglas G Ward, Joseph M Foster, et al.
Trials|May 30, 2019
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocolsFrancesca Schiavone, Riya Bathia, Krishna Letchemanan, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisLarysa H M Rydzewska, Sarah Burdett, Claire L Vale, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort StudySylvia H J Jochems, Frits H M van Osch, Raoul C Reulen, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
Trials|September 18, 2012
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trialMatthew R Sydes, Mahesh K B Parmar, Malcolm D Mason, et al.
BJU International|September 7, 2021
Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot studyNaheema S Gordon, Laura A Baxter, Anshita Goel, et al.
Genome Medicine|June 2, 2022
Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomesAnshita Goel, Douglas G Ward, Boris Noyvert, et al.
Plos One|February 23, 2016
Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder CancerDouglas G Ward, Laura Baxter, Naheema S Gordon, et al.
Nature|August 31, 2018
Required growth facilitators propel axon regeneration across complete spinal cord injuryMark A Anderson, Timothy M O'Shea, Joshua E Burda, et al.
European Journal of Human Genetics : EJHG|January 14, 2016
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNAFiona S Togneri, Douglas G Ward, Joseph M Foster, et al.
Trials|May 30, 2019
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocolsFrancesca Schiavone, Riya Bathia, Krishna Letchemanan, et al.
Pageof 20